November 14, 2016

FERRING PHARMACEUTICALS HIGHLIGHTS ONGOING SPONSORSHIP OF ARTHRITIS FOUNDATION THROUGH FUNDRAISING EVENTS

PARSIPPANY, N.J., Nov. 14, 2016 /PRNewswire/ — Ferring Pharmaceuticals Inc. will continue its leadership role as one of four national sponsors for the more than 100 Arthritis Foundation Jingle Bell Run events taking place in cities across the country. Through this sponsorship, Ferring Pharmaceuticals will support the Arthritis Foundation’s search for a cure to the number one cause of disability in the United States, while also providing life-changing tools, resources, and science and advocacy initiatives to help arthritis sufferers in their daily lives.

More than 50 million Americans are diagnosed with arthritis, 27 million of whom suffer from osteoarthritis. “Our mission is to help patients live better lives. Through our national sponsorship of Jingle Bell Run, we can support not only patients with osteoarthritis, but all who struggle with arthritis and their families,” says Joseph Rizzo, Marketing Manager, Orthopaedics.

Beyond sponsorship of the annual fundraising event, Ferring has a longstanding partnership with the Arthritis Foundation to take action and address vital issues in the prevention, control and cure of arthritis. Ferring employees from around the country are also joining the initiative by taking part in local events to help raise funds to conquer arthritis. Last year’s winner of the 5K in Virginia Beach, Virginia was a Ferring employee.

“The work we do day in and day out in the support of healthcare professionals and their patients highlights the importance of investing in the future of arthritis treatment,” said David Powley, Senior Director, Ferring Pharmaceuticals Inc. “We’re proud to participate in this event both on the corporate level and through the many employees who make it a priority to demonstrate their personal support.”

Find your local event by visiting www.arthritis.org/jbr. To learn more about the fight to conquer arthritis, visit www.arthritis.org.

About Ferring Pharmaceuticals
Ferring Pharmaceuticals Inc. is a subsidiary of Ferring Pharmaceuticals, a privately owned, international pharmaceutical company. Ferring Pharmaceuticals specializes in the research, development and commercialization of compounds in general and pediatric endocrinology, gastroenterology, infertility, obstetrics/gynecology, orthopaedics, and urology. For more information, call 1-888-FERRING (1-888-337-7464) or visit www.FerringUSA.com.

About the Arthritis Foundation
The Arthritis Foundation is the Champion of Yes. Leading the fight for the arthritis community, the Foundation helps conquer everyday battles through life-changing information and resources, access to optimal care, advancements in science and community connections. The Arthritis Foundation’s goal is to chart a winning course, guiding families in developing personalized plans for living a full life – and making each day another stride towards a cure. The Foundation also publishes Arthritis Today, the award-winning magazine that reaches 4 million readers.

Media Contact
Yvonne Lachmann
410-627-9749
Yvonne.Lachmann@bm.com

© 2016 Ferring B.V. 11/14 [EU/2403/2016/US]

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring's employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring.

All information on this site is intended for US audiences only.

CERVIDIL, EUFLEXXA, FIRMAGON, and PREPOPIK are registered trademarks of Ferring B.V. ZOMACTON is a trademark of Ferring B.V.

©2008-2015 Ferring Pharmaceuticals.  GC/1722/2014/US(4)